Development of oral anticoagulants
- PMID: 17506786
- PMCID: PMC2000654
- DOI: 10.1111/j.1365-2125.2007.02898.x
Development of oral anticoagulants
Comment on
-
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.Br J Clin Pharmacol. 2007 Sep;64(3):292-303. doi: 10.1111/j.1365-2125.2007.02899.x. Epub 2007 May 15. Br J Clin Pharmacol. 2007. PMID: 17506785 Free PMC article. Clinical Trial.
References
-
- Weitz JI. A novel approach to thrombin inhibition. Thromb Res. 2003;109(Suppl 1):S17–22. - PubMed
-
- Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation. 2003;107:1692–711. - PubMed
-
- Bauer KA. New anticoagulants: anti IIa vs anti Xa – is one better? J Thromb Thrombolysis. 2006;21:67–72. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
